Novartis produces first batch of swine flu vaccine

Jun 12, 2009

Swiss drugs giant Novartis has completed a first batch of swine flu vaccine for pre-clinical trials and aims to make a version available in the fall, the company said Friday.

" has successfully completed the production of the first batch of A(H1N1) , weeks ahead of expectations," the company said in a statement.

The 10-litre batch "will be used for pre-clinical evaluation and testing and is also being considered for use in clinical trials," it said.

Novartis hopes to start clinical trials in July and "expects licensure in the fall of 2009," it said.

It added that "more than 30 governments have made requests to Novartis to supply them with influenza A(H1N1) vaccine ingredients."

The company used cell-based technology to produce the vaccine, a faster method than the traditional technology that uses eggs, according to Novartis.

Novartis received 289 million dollars (206.8 million euros) last month from the US Department of Health and Human Services for the development of the vaccine.

The World Health Organization declared a pandemic on Thursday, ratcheting up its alert to the maximum level of six.

Swine flu has infected people almost 30,000 people in 75 countries and claimed 144 lives since it was first detected in Mexico in April.

(c) 2009 AFP

Explore further: Recorded Ebola deaths top 7,000

add to favorites email to friend print save as pdf

Related Stories

GlaxoSmithKline taking pandemic vaccine orders

May 15, 2009

(AP) -- Pharmaceutical giant GlaxoSmithKline said Friday it has received orders from several countries to stockpile pandemic vaccine as soon as it gets the vaccine's key ingredient from the World Health Organization.

Glaxo offers WHO 50 million pandemic vaccines

May 19, 2009

(AP) -- Drug giant GlaxoSmithKline said it has offered to donate 50 million doses of a pandemic vaccine to the World Health Organization in the event of a global flu outbreak, according to a company spokesman.

WHO meets on production of swine flu vaccine

May 14, 2009

(AP) -- As swine flu cases hit 6,500 worldwide, World Health Organization officials were meeting with vaccine manufacturers and other experts in Geneva on Thursday to discuss making a vaccine to fight the virus.

WHO: No swine flu vaccine available for months (Update)

May 19, 2009

(AP) -- Drug manufacturers won't be able to start making a swine flu vaccine until mid-July at the earliest, weeks later than previous predictions, the World Health Organization said Tuesday. It will then ...

Recommended for you

Recorded Ebola deaths top 7,000

7 hours ago

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

11 hours ago

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

Bacteria in caramel apples kills at least four in US

Dec 19, 2014

A listeria outbreak believed to originate from commercially packaged caramel apples has killed at least four people in the United States and sickened 28 people since November, officials said Friday.

Steroid-based treatment may answer needs of pediatric EoE patients

Dec 19, 2014

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

Nan2
not rated yet Jun 16, 2009
LONDON (Reuters) - Swiss drugs company Novartis will not give free vaccines against H1N1 flu to poor countries, though it will consider discounts, the Financial Times reported on Sunday.

"If you want to make production sustainable, you have to create financial incentives," the FT quoted Novartis Chief Executive Daniel Vasella as saying in an early edition of Monday's paper.

The director-general of the World Health Organization, Margaret Chan, has called for drugs companies to show solidarity with poor countries as they develop vaccines against the pandemic H1N1 virus, commonly known as swine flu.

As well as Novartis, U.S. company Baxter International and Europe's Sanofi-Aventis, GlaxoSmithKline and Solvay are working on vaccines.

H1N1 has infected around 30,000 people globally, mostly in North America, though there have been few deaths outside Mexico and the United States. Europe suffered its first death on Sunday after a patient with pre-existing health problems died in Scotland.

(Reporting by David Milliken; Editing Bernard Orr)

http://www.reuter...20090614

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.